News

Doctor, can I have an extra cup of caffeine? Researchers performed a systematic review of studies of caffeine consumption and clinical symptoms in patients with bipolar disorder.

Some patients are intractably and maybe even irredeemably ill. What should be done for them?

A diverse group of psychiatrists elaborates on the difficult conversation surrounding reparations, and why our society needs to pay attention.

A clinical review of an effective approach for treatment-resistant depression.

Key questions to consider when evaluating a digital therapeutic for anxiety.

Artificial intelligence and natural language processing provide powerful new tools to measure thought disorder and negative symptoms in schizophrenia.

Manufactured fentanyl is a major cause of overdoses for opioids and nonopiods. Can a vaccine immunize against overdose?

We need policies that make digital therapeutics accessible and acceptable to a broad patient audience. What barriers are there to reaching that goal?

How can State Physician Health Programs guide your care of physician patients?

What will psychiatric practice look like in the year 2030?

Digital therapeutics need to be integrated into care ethically, but how?

Two Black doctors caring for a Black patient left one doctor feeling proud.

Is collaborative practice still needed?

Could the emerging field of epigenetics hold the key to catching postpartum depression before it happens?

What are the greatest unmet mental health needs in the United States today? Recent statistics from the Centers for Disease Control may hold the answers.

Our country’s mental health depends on defeating this pandemic. The key to victory? Vaccine mandates.

Proponents of medical aid in dying often accuse their opponents of lacking compassion. But what does that word really mean?

How can digital therapeutics more readily be brought into the hands of patients with serious mental illnesses?

Some people are easier to read than others...

Why are mental health digital therapeutics primarily based on CBT?

A new study finds amyloid plaques accelerate the breakup of neurotransmitters, worsening neurodegenerative diseases like Alzheimer disease.

Travelling the world with his camera, a psychiatrist searches for our common humanity. What is it that binds us all together?

Only a few digital therapeutics are currently FDA approved. What options are available and how can they best be leveraged for the benefit of patients?

It's important to be mindful of those nagging itches and what they may really represent.

Digital therapeutics may be the biggest paradigm-shifting change medicine has seen yet...

The documentary Orchestrating Change has won the 2021 Austen Riggs Erikson Prize for Excellence in Mental Health Media.

After the past year's lockdowns, making time for meaningful connections becomes more important than ever.

One doctor argues that assisted suicide is just that—suicide, not murder—and should be available for some patients.

More potential good news for treating Alzheimer disease, as an 18-month open-label extension for lecanemab allows for its breakthrough status.

Clinical experiences and insights in this Case-Based Psych Perspectives were shared by Leslie L. Citrome, MD, MPH, a psychiatry specialist from Valhalla, New York, and Rose Mary Xavier, PhD, MS, RN, PMHNP-BC, a research scientist and psychiatric nurse practitioner from Chapel Hill, North Carolina. This article provides a summary of key discussion topics from this custom program.